EMPROVE® exp Portfolio by Merck

As drug approval procedures grow stricter, regulatory requirements are becoming more demanding for excipients. Our high-quality EMPROVE® exp raw materials for use as excipients not only comply with relevant regulations, but also come with detailed documentation, facilitating lower costs of qualification, so you can get to market faster.

EMPROVE® exp dossiers comprise information on the manufacturer and manufacturing process. They provide specifications in accordance with the requirements of a variety of pharmacopoeias, as well as details on impurities, stability data and a certificate of analysis (CoA). This way, we help reduce your workload and accelerate your qualification processes.


EMPROVE® exp Portfolio Features:

• Complete Dossier (Basic, Analytical, Stability-Dossier)
  - Update every 12 month
  - CDA necessary
  - Charged
• Basic Dossier
  - Available online
  - Free of charge
• Analytical Dossier (Basic Dossier+Analytical Method)
  - CDA necessary
  - Charged
• Stability Dossier
  (Basic Dossier+Stability Method)
  - CDA necessary
  - Charged